Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.

Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.

BACKGROUND & AIMS:HBV-related acute-on-chronic liver failure (HBV-ACLF) is a severe liver disease which results in a high mortality in China. To early predict the prognosis of the patients may prevent the complications and improve the survival. This study was aimed to develop a new prognostic in...

Full description

Bibliographic Details
Main Authors: Zhihong Wan, Yichen Wu, Jing Yi, Shaoli You, Hongling Liu, Zhiqiang Sun, Bing Zhu, Hong Zang, Chen Li, Fangfang Liu, Dongze Li, Yuanli Mao, Shaojie Xin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4309543?pdf=render

Internet

http://europepmc.org/articles/PMC4309543?pdf=render

Similar Items